These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19195510)

  • 21. Serial intravascular ultrasound analysis of stent strut distribution and fracture: an integrated analysis of the taxus IV, V, and VI trials.
    Pracon R; Opolski MP; Mintz GS; Pregowski J; Kruk M; Popma JJ; Mandinov L; Wang H; Ellis SG; Grube E; Dawkins KD; Stone GW; Weissman NJ
    J Invasive Cardiol; 2014 Oct; 26(10):501-11. PubMed ID: 25274860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
    Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
    JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.
    Mehilli J; Byrne RA; Tiroch K; Pinieck S; Schulz S; Kufner S; Massberg S; Laugwitz KL; Schömig A; Kastrati A;
    J Am Coll Cardiol; 2010 Jun; 55(24):2710-6. PubMed ID: 20226618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation.
    Tanabe K; Serruys PW; Grube E; Smits PC; Selbach G; van der Giessen WJ; Staberock M; de Feyter P; Müller R; Regar E; Degertekin M; Ligthart JM; Disco C; Backx B; Russell ME
    Circulation; 2003 Feb; 107(4):559-64. PubMed ID: 12566366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
    Dawkins KD; Grube E; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Koglin J; Russell ME;
    Circulation; 2005 Nov; 112(21):3306-13. PubMed ID: 16286586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents.
    Werner GS; Krack A; Schwarz G; Prochnau D; Betge S; Figulla HR
    J Am Coll Cardiol; 2004 Dec; 44(12):2301-6. PubMed ID: 15607390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patency of paclitaxel-eluting versus bare metal stents long term after implantation in acute ST-segment elevation myocardial infarction.
    Vink MA; Van Nooijen FC; Laarman GJ; Suttorp MJ; Tijssen JG; Slagboom T; Patterson MS; Van Der Schaaf RJ; Kiemeneij F; Amoroso G; Dirksen MT
    Am J Cardiol; 2011 Nov; 108(9):1214-9. PubMed ID: 21864813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease.
    Lansky AJ; Costa RA; Mooney M; Midei MG; Lui HK; Strickland W; Mehran R; Leon MB; Russell ME; Ellis SG; Stone GW;
    J Am Coll Cardiol; 2005 Apr; 45(8):1180-5. PubMed ID: 15837246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Volumetric intravascular ultrasound analysis of Paclitaxel-eluting and bare metal stents in acute myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudy.
    Maehara A; Mintz GS; Lansky AJ; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Parise H; Mehran R; Stone GW
    Circulation; 2009 Nov; 120(19):1875-82. PubMed ID: 19858413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of coronary artery bypass grafting following implantation of a paclitaxel-eluting or a bare-metal stent into a single coronary artery.
    Martin JL; Ellis SG; Colombo A; Grube E; Maloney T; Friedman MI; Baim DS; Dawkins K; Caputo R; Stone GW
    Am J Cardiol; 2009 Jan; 103(1):11-6. PubMed ID: 19101222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the distance from the stent edge to the residual plaque on edge restenosis following everolimus-eluting stent implantation.
    Takahashi M; Miyazaki S; Myojo M; Sawaki D; Iwata H; Kiyosue A; Higashikuni Y; Tanaka T; Fujita D; Ando J; Fujita H; Hirata Y; Komuro I
    PLoS One; 2015; 10(3):e0121079. PubMed ID: 25775115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of the effects of paclitaxel-eluting stents versus bare metal stents on volumetric intravascular ultrasound in patients with versus without diabetes mellitus.
    Kimura M; Mintz GS; Weissman NJ; Dawkins KD; Grube E; Ellis SG; Cannon LA; Masud Z; Mandinov L; Baim D; Stone GW
    Am J Cardiol; 2008 May; 101(9):1263-8. PubMed ID: 18435955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials).
    Aoki J; Mintz GS; Weissman NJ; Mandinov L; Grube E; Dawkins KD; Ellis SG; Greenberg J; Yu A; Mann JT; Cannon L; Cambier PA; Stone GW
    Am J Cardiol; 2008 Oct; 102(8):1009-16. PubMed ID: 18929701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravascular ultrasound assessment of expansion of the sirolimus-eluting (cypher select) and paclitaxel-eluting (Taxus Express-2) stent in patients with diabetes mellitus.
    Jensen LO; Maeng M; Mintz GS; Christiansen EH; Hansen KN; Galloe A; Kelbaek H; Hansen HS; Joergensen E; Lassen JF; Thuesen L; Thayssen P
    Am J Cardiol; 2008 Jul; 102(1):19-26. PubMed ID: 18572030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymer-based paclitaxel-eluting stent for treatment of chronic total occlusions of native coronaries: results of a Taxus CTO registry.
    Buellesfeld L; Gerckens U; Mueller R; Schmidt T; Grube E
    Catheter Cardiovasc Interv; 2005 Oct; 66(2):173-7. PubMed ID: 16144017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TAXUS Liberté attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program.
    Mahmud E; Ormiston JA; Turco MA; Popma JJ; Weissman NJ; O'Shaughnessy CD; Mann T; Hall JJ; McGarry TF; Cannon LA; Webster MW; Mandinov L; Baim DS
    JACC Cardiovasc Interv; 2009 Mar; 2(3):240-52. PubMed ID: 19463432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.
    Chevalier B; Silber S; Park SJ; Garcia E; Schuler G; Suryapranata H; Koolen J; Hauptmann KE; Wijns W; Morice MC; Carrie D; van Es GA; Nagai H; Detiege D; Paunovic D; Serruys PW;
    Circ Cardiovasc Interv; 2009 Jun; 2(3):188-95. PubMed ID: 20031715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Taxus polymer-coated paclitaxel-eluting stents for treatment of in-stent restenosis in real world patients: results of clinical and angiographic follow-up at six months in a single-center registry.
    Lim VY; Buellesfeld L; Gerckens U; Mueller R; Schmidt T; Grube E
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):343-8. PubMed ID: 16897778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stent malapposition after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: acute and 9-month intravascular ultrasound results of the MISSION! intervention study.
    van der Hoeven BL; Liem SS; Dijkstra J; Bergheanu SC; Putter H; Antoni ML; Atsma DE; Bootsma M; Zeppenfeld K; Jukema JW; Schalij MJ
    JACC Cardiovasc Interv; 2008 Apr; 1(2):192-201. PubMed ID: 19463300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial.
    Halkin A; Mehran R; Casey CW; Gordon P; Matthews R; Wilson BH; Leon MB; Russell ME; Ellis SG; Stone GW
    Am Heart J; 2005 Dec; 150(6):1163-70. PubMed ID: 16338253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.